Medicated-Assisted Treatment in Indiana

Simple item page
dc.contributor.authorKooreman, Harold
dc.date.accessioned2024-02-19T19:29:41Z
dc.date.available2024-02-19T19:29:41Z
dc.date.issued2019-03
dc.description.abstractOpioid misuse and addiction continues to affect many Americans. Medication-assisted treatment (MAT) using methadone, buprenorphine, or extended-release naltrexone in combination with behavioral therapy is the most effective intervention for opioid use disorders (OUDs). Despite its effectiveness, methadone to treat OUDs is not widely available. Buprenorphine is more accessible, as it can be prescribed by medical doctors, nurse practitioners, and physician assistants who have received specialized training and obtained a waiver from the DEA. Naltrexone is a non-narcotic and can be prescribed by any healthcare professional who has prescription privileges.
dc.identifier.urihttps://hdl.handle.net/1805/38553
dc.language.isoen_US
dc.publisherRichard M. Fairbanks School of Public Health
dc.subjectopioids
dc.subjectdrugs
dc.subjectaddition
dc.subjectindiana
dc.titleMedicated-Assisted Treatment in Indiana
dc.typeReport
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
Medicated-Assisted-Treatment-in-Indiana.pdf
Size:
1.75 MB
Format:
Adobe Portable Document Format
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.99 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Center for Health Policy, IU Richard M. Fairbanks School of Public Health